Your browser doesn't support javascript.
loading
Doxorubicin, vinblastine, dacarbazine and lenalidomide for older Hodgkin lymphoma patients: final results of a German Hodgkin Study Group (GHSG) phase-I trial.
Böll, Boris; Plütschow, Annette; Bürkle, Carolin; Atta, Johannes; Pfreundschuh, Michael; Feuring-Buske, Michaela; Vogelhuber, Martin; Sökler, Martin; Eichenauer, Dennis A; Thielen, Indra; von Tresckow, Bastian; Fuchs, Michael; Engert, Andreas; Borchmann, Peter.
Afiliación
  • Böll B; German Hodgkin Study Group (GHSG), Department of Internal Medicine 1, University Hospital Cologne, Cologne, Germany.
  • Plütschow A; German Hodgkin Study Group (GHSG), Department of Internal Medicine 1, University Hospital Cologne, Cologne, Germany.
  • Bürkle C; German Hodgkin Study Group (GHSG), Department of Internal Medicine 1, University Hospital Cologne, Cologne, Germany.
  • Atta J; Haematology Oncology, University Hospital Frankfurt, Frankfurt, Germany.
  • Pfreundschuh M; Haematology Oncology, University Hospital Saarland, Homburg, Germany.
  • Feuring-Buske M; Haematology Oncology, University Hospital Ulm, Ulm, Germany.
  • Vogelhuber M; Haematology Oncology, University Hospital Regensburg, Regensburg, Germany.
  • Sökler M; Haematology Oncology, University Hospital Tübingen, Tübingen, Germany.
  • Eichenauer DA; German Hodgkin Study Group (GHSG), Department of Internal Medicine 1, University Hospital Cologne, Cologne, Germany.
  • Thielen I; German Hodgkin Study Group (GHSG), Department of Internal Medicine 1, University Hospital Cologne, Cologne, Germany.
  • von Tresckow B; German Hodgkin Study Group (GHSG), Department of Internal Medicine 1, University Hospital Cologne, Cologne, Germany.
  • Fuchs M; German Hodgkin Study Group (GHSG), Department of Internal Medicine 1, University Hospital Cologne, Cologne, Germany.
  • Engert A; German Hodgkin Study Group (GHSG), Department of Internal Medicine 1, University Hospital Cologne, Cologne, Germany.
  • Borchmann P; German Hodgkin Study Group (GHSG), Department of Internal Medicine 1, University Hospital Cologne, Cologne, Germany.
Br J Haematol ; 185(1): 42-52, 2019 04.
Article en En | MEDLINE | ID: mdl-30592027
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedad de Hodgkin / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Br J Haematol Año: 2019 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedad de Hodgkin / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Br J Haematol Año: 2019 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Reino Unido